Envista to acquire osteogenics biomedical business

Brea, calif. , may 17, 2022  /prnewswire/ -- envista holdings corporation (nyse: nvst) ("envista") today announced it has entered into a definitive agreement to acquire osteogenics biomedical inc, allotech llc and obi biologics, inc (together "osteogenics").
NVST Ratings Summary
NVST Quant Ranking